RGD Reference Report - The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.

Authors: Ehler, Johannes  Petzold, Axel  Wittstock, Matthias  Kolbaske, Stephan  Gloger, Martin  Henschel, Jörg  Heslegrave, Amanda  Zetterberg, Henrik  Lunn, Michael P  Rommer, Paulus S  Grossmann, Annette  Sharshar, Tarek  Richter, Georg  Nöldge-Schomburg, Gabriele  Sauer, Martin 
Citation: Ehler J, etal., PLoS One. 2019 Jan 24;14(1):e0211184. doi: 10.1371/journal.pone.0211184. eCollection 2019.
RGD ID: 27226881
Pubmed: PMID:30677080   (View Abstract at PubMed)
PMCID: PMC6345472   (View Article at PubMed Central)
DOI: DOI:10.1371/journal.pone.0211184   (Journal Full-text)

Sepsis-associated encephalopathy (SAE) contributes to mortality and neurocognitive impairment of sepsis patients. Neurofilament (Nf) light (NfL) and heavy (NfH) chain levels as biomarkers for neuroaxonal injury were not evaluated in cerebrospinal fluid (CSF) and plasma of patients with sepsis-associated encephalopathy (SAE) before. We conducted a prospective, pilot observational study including 20 patients with septic shock and five patients without sepsis serving as controls. The assessment of SAE comprised a neuropsychiatric examination, electroencephalography (EEG), magnetic resonance imaging (MRI) and delirium screening methods including the confusion assessment method for the ICU (CAM-ICU) and the intensive care delirium screening checklist (ICDSC). CSF Nf measurements in sepsis patients and longitudinal plasma Nf measurements in all participants were performed on days 1, 3 and 7 after study inclusion. Plasma NfL levels increased in sepsis patients over time (p = 0.0063) and remained stable in patients without sepsis. Plasma NfL values were significantly higher in patients with SAE (p = 0.011), significantly correlated with the severity of SAE represented by ICDSC values (R = 0.534, p = 0.022) and correlated with a poorer functional outcome after 100 days (R = -0.535, p = 0.0003). High levels of CSF Nf were measured in SAE patients. CSF NfL levels were higher in non-survivors (p = 0.012) compared with survivors and correlated with days until death (R = -0.932, p<0.0001) and functional outcome after 100 days (R = -0.749, p<0.0001). The present study showed for the first time that Nf levels provide complementary prognostic information in SAE patients indicating a higher chance of death and poorer functional/cognitive outcome in survivors.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Sepsis severityIEP 27226881 RGD 
Sepsis disease_progressionIEP 27226881 RGD 
Sepsis severityISONEFH (Homo sapiens)27226881; 27226881 RGD 
Sepsis disease_progressionISONEFL (Homo sapiens)27226881; 27226881 RGD 
Sepsis-Associated Encephalopathy severityIEP 27226881 RGD 
Sepsis-Associated Encephalopathy disease_progressionIEP 27226881 RGD 
Sepsis-Associated Encephalopathy severityISONEFH (Homo sapiens)27226881; 27226881 RGD 
Sepsis-Associated Encephalopathy disease_progressionISONEFL (Homo sapiens)27226881; 27226881 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Nefh  (neurofilament heavy chain)
Nefl  (neurofilament light chain)

Genes (Mus musculus)
Nefh  (neurofilament, heavy polypeptide)
Nefl  (neurofilament, light polypeptide)

Genes (Homo sapiens)
NEFH  (neurofilament heavy chain)
NEFL  (neurofilament light chain)


Additional Information